Primary Hyperlipidemia and Mixed Dyslipidemia
1 clinical trials · Condition
◉ Watch Primary Hyperlipidemia and Mixed Dyslipidemia
| Record | Firm | Date |
|---|---|---|
| Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody (NCT02189837) | Amgen | 2014-07-08 |
Track Primary Hyperlipidemia and Mixed Dyslipidemia automatically
Every clearance here is in the API, with alerts when new ones post.